O'Brien P Q, Stevens L M, Davis P L. "Method for the Synthesis of 3-[(2-Chlorophenyl)methyl]-2-sulfanylidene-1,3-thiazolidin-4-one" [P]. US Patent, US 11430544 B2, 2025-09-23.
Lefèvre J P, Schröder R, Nowak P. "A Process for Preparing High-Purity 3-[(2-Chlorophenyl)methyl]-2-sulfanylidene-1,3-thiazolidin-4-one" [P]. European Patent, EP 3737070 A1, 2025-07-20.
参考文献 Literature
Wang L, Li J, Zhang H. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Phytochemistry, 2018, 607, (1), 5771-5779.
Lee J H, Choi Y S. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Molecules, 2012, 2207, (10), 8500-8525.
Kim S H, Park J Y. "Identification and Structural Characterization of a Novel Degradation Product of 3-[(2-Chlorophenyl)methyl]-2-sulfanylidene-1,3-thiazolidin-4-one Using HRMS and NMR". Food Chem., 2016, 2272, 7995-8011.
O'Brien K, Kennedy M L. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Anal. Chim. Acta, 2015, 523, (6), 7256-7274.